Issue 34, 2022

Synthesis and anti-microbial activity of a new series of bis(diphosphine) rhenium(v) dioxo complexes

Abstract

Rhenium-based metallodrugs have recently been highlighted as promising candidates for new antibiotics to combat multi-drug resistant (MDR) pathogens. A new class of rhenium(V) dioxo complexes were prepared from readily accessible diphosphine ligands, and have been shown to possess potent activity against Staphylococcus aureus (S. aureus) and Candida albicans (C. albicans) alongside low human cell toxicity.

Graphical abstract: Synthesis and anti-microbial activity of a new series of bis(diphosphine) rhenium(v) dioxo complexes

Supplementary files

Article information

Article type
Communication
Submitted
05 Jul 2022
Accepted
25 Jul 2022
First published
03 Aug 2022
This article is Open Access
Creative Commons BY license

Dalton Trans., 2022,51, 12791-12795

Synthesis and anti-microbial activity of a new series of bis(diphosphine) rhenium(V) dioxo complexes

S. M. Cooper, C. Siakalli, A. J. P. White, A. Frei, P. W. Miller and N. J. Long, Dalton Trans., 2022, 51, 12791 DOI: 10.1039/D2DT02157A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements